The formation of AAB comes at a pivotal moment, with the National Security Commission on Emerging Biotechnology (NSCEB) calling for a coordinated, whole-of-government strategy to ensure U.S. global leadership in industrial biomanufacturing.
The Alliance will focus on two key objectives: (1) supercharging U.S. demand for bio-based products and technologies; and (2) ensuring market readiness for existing and novel bioproducts. It will also seek to strengthen domestic supply chains for biological materials, equipment, and technologies to enhance U.S. global competitiveness.